ASX Share rice
Thu 13 Aug 2020 - 03:34:am (Sydney)

ACW Share Price

ACTINOGEN MEDICAL LIMITEDACWPharmaceuticals, Biotechnology & Life Sciences

ACW Company Information


Actinogen Medical Limited





GIC Industry:


GIC Sub Industry:



109 Pitt Street Sydney NSW Australia 2000


61 2 8964 7401

MD, CEO & Director:

Dr. John William Ketelbey MBBCH, FFPM, MBA, GAICD

Company Sec.:

Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD

Company Overview:

Actinogen Medical Limited, a biotechnology company, develops treatments for Alzheimer's disease, and the cognitive deficiency associated with other neurological and metabolic diseases in Australia. It is developing Xanamem, a therapy for Alzheimer's disease; and XanADu, which has completed Phase II clinical trials is a double-blind, randomized, placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's disease. The company is also developing XanaHES, a Phase I, single blinded, central reader blinded, placebo-controlled, dose escalation study of Xanamem to assess safety and tolerability in healthy elderly subjects. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited is based in Sydney, Australia.

ACW Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


ACW CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Capital Expenditures:


ACW Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


ACW Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


ACW Share Price History

ACW News

15 Apr, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
17 Dec, 2019
Actinogen Medical Limited (ASX:ACW) shareholders will doubtless be very grateful to see the share price up 350% in the...
18 Oct, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
01 Oct, 2019
SYDNEY-- -- Statistically significant results demonstrate cognitive improvement in healthy elderly subjects dosed with 20mg Xanamem daily in the XanaHES dose escalation study Statistically significant reduction in serum cortisol following treatment with Xanamem 20mg daily Xanamem 20mg daily continues to exhibit a good safety profile with no serious adverse events observed Results significantly enhance ...
12 Sep, 2019
The big shareholder groups in Actinogen Medical Limited (ASX:ACW) have power over the company. Institutions will often...